NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.25
+0.07 (0.97%)
Apr 2, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $81.11 million as of April 2, 2026. Its market cap has increased by 393.55% in one year.
Market Cap
81.11M
Enterprise Value
76.57M
1-Year Change
393.55%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $81.11M, an increase of 341.49%. That is a compound annual growth rate of 75.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 81.11M | 67.71% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 83.78M |
| aTyr Pharma | 83.42M |
| Filana Therapeutics | 83.09M |
| Champions Oncology | 82.14M |
| Kazia Therapeutics | 82.05M |
| Gain Therapeutics | 81.95M |
| Pliant Therapeutics | 81.73M |
| MAIA Biotechnology | 81.30M |